Skip to main content

Table 2 Number (%) of cases with complications

From: Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study

Variables

GADA

Control

(n = 21)

(n = 19)

Hypertension, n (%)

9 (43%)

12 (63%)

Dyslipidemia, n (%)

8 (38%)

10 (53%)

Current smoker, n (%)

2 (10%)

3 (15%)

Diabetic retinopathy, n (%)

3 (14%)

5 (26%)

Diabetic nephropathy, n (%)

4 (19%)

8 (42%)

Diabetic neuropathy, n (%)

4 (19%)

5 (26%)

Small vessel disease on MRI, n (%)

3 (14%)

5 (26%)

  1. Fisher exact tests showed no significant differences.
  2. Abbreviations: GADA glutamic acid decarboxylase antibody.